TOP TEN perturbations for 39683_at (Homo sapiens)
Organism: Homo sapiens
Gene: 39683_at
Selected probe(set): 206185_at
Platform: Affymetrix Human Genome U133 Plus 2.0 Array
Expression of 39683_at (206185_at) across 6674 perturbations tested by GENEVESTIGATOR:
OPM-1 / MM1.S
Relative Expression (log2-ratio):-5.738163Number of Samples:4 / 4
| Experimental | OPM-1 |
| Human primary cancer cell line derived from the peripheral blood of a patient with multiple myeloma. Dexamethasone-resistant. Synonyms:OPM1 Cellosaurus code: | |
| Control | MM1.S |
| Human primary cancer cell line derived from the peripheral blood of a patient with multiple myeloma. Dexamethasone-sensitive. Parental cell line:: MM.1 Synonyms:MM.1S; MM1-S; MM-1S; MM1S Cellosaurus code: |
embryonic development study 1 (9wk) / embryonic development study 1 (4wk)
Relative Expression (log2-ratio):2.3022823Number of Samples:3 / 3
| Experimental | embryonic development study 1 (9wk) |
| Human embryos at 9th week after fertilization. Embryos were obtained after therapeutic termination of pregnancy with mifepristone. | |
| Control | embryonic development study 1 (4wk) |
| Human embryos at 4th week after fertilization. Embryos were obtained after therapeutic termination of pregnancy with mifepristone. |
conditioned medium study 1 (HS27a) / untreated monocyte (CD14+) sample
Relative Expression (log2-ratio):1.7186909Number of Samples:2 / 2
| Experimental | conditioned medium study 1 (HS27a) |
| CD14+ monocytes treated with HS27a conditioned medium (CM) for 48h. | |
| Control | untreated monocyte (CD14+) sample |
| Untreated CD14+ monocytes from two different donors. |
influenza virus study 11 (A/H5N3) / influenza virus study 4 (A/H1N1)
Relative Expression (log2-ratio):-1.692339Number of Samples:3 / 3
| Experimental | influenza virus study 11 (A/H5N3) |
| Human carcinoma cell line A549 infected with influenza A virus subtype influenza virus A/duck/Malaysia/F119/3/1997(H5N3). Samples were taken 10 hours post-infection. | |
| Control | influenza virus study 4 (A/H1N1) |
| Human carcinoma cell line A549 infected with influenza A virus subtype A/WSN/33 (H1N1). Samples were taken 10 hours post-infection. |
influenza virus study 9 (A/pH1N1) / influenza virus study 4 (A/H1N1)
Relative Expression (log2-ratio):-1.6136265Number of Samples:3 / 3
| Experimental | influenza virus study 9 (A/pH1N1) |
| Human carcinoma cell line A549 infected with influenza A virus subtype [A/Singapore/478/2009 (pH1N1)]. Samples were taken 10 hours post-infection. | |
| Control | influenza virus study 4 (A/H1N1) |
| Human carcinoma cell line A549 infected with influenza A virus subtype A/WSN/33 (H1N1). Samples were taken 10 hours post-infection. |
influenza virus study 10 (A/H5N2) / influenza virus study 4 (A/H1N1)
Relative Expression (log2-ratio):-1.5137243Number of Samples:3 / 3
| Experimental | influenza virus study 10 (A/H5N2) |
| Human carcinoma cell line A549 infected with influenza A virus subtype influenza virus A/duck/Malaysia/F189/07/2004(H5N2). Samples were taken 10 hours post-infection. | |
| Control | influenza virus study 4 (A/H1N1) |
| Human carcinoma cell line A549 infected with influenza A virus subtype A/WSN/33 (H1N1). Samples were taken 10 hours post-infection. |
influenza virus study 9 (A/H5N2) / influenza virus study 4 (A/H1N1)
Relative Expression (log2-ratio):-1.3961048Number of Samples:3 / 3
| Experimental | influenza virus study 9 (A/H5N2) |
| Human carcinoma cell line A549 infected with influenza A virus subtype A/duck/Malaysia/F118/08/2004(H5N2). Samples were taken 10 hours post-infection. | |
| Control | influenza virus study 4 (A/H1N1) |
| Human carcinoma cell line A549 infected with influenza A virus subtype A/WSN/33 (H1N1). Samples were taken 10 hours post-infection. |
Dengue hemorrhagic fever study 1 (5d) / Dengue hemorrhagic fever study 1 (convalescent)
Relative Expression (log2-ratio):1.3811674Number of Samples:5 / 12
| Experimental | Dengue hemorrhagic fever study 1 (5d) |
| Peripheral blood mononuclear cell (PBMC) samples derived from the blood of Venezuelan individuals 5 days after the onset of Dengue hemorrhagic fever. | |
| Control | Dengue hemorrhagic fever study 1 (convalescent) |
| Peripheral blood mononuclear cell (PBMC) samples derived from the blood of Venezuelan individuals 28 days after the onset of Dengue hemorrhagic fever. |
influenza virus study 9 (A/H9N2) / influenza virus study 4 (A/H1N1)
Relative Expression (log2-ratio):-1.3593521Number of Samples:3 / 3
| Experimental | influenza virus study 9 (A/H9N2) |
| Human carcinoma cell line A549 infected with influenza A virus subtype A/Duck/Malaysia/01 (H9N2). Samples were taken 10 hours post-infection. | |
| Control | influenza virus study 4 (A/H1N1) |
| Human carcinoma cell line A549 infected with influenza A virus subtype A/WSN/33 (H1N1). Samples were taken 10 hours post-infection. |
Dengue fever study 5 (late) / Dengue fever study 1 (convalescent)
Relative Expression (log2-ratio):1.2388945Number of Samples:5 / 11
| Experimental | Dengue fever study 5 (late) |
| Peripheral blood mononuclear cell (PBMC) samples derived from the blood of Venezuelan individuals 5 days after the onset of Dengue fever. | |
| Control | Dengue fever study 1 (convalescent) |
| Peripheral blood mononuclear cell (PBMC) samples derived from the blood of Venezuelan individuals 28 days after the onset of Dengue fever. |